What is the most important residual risk after achievement of appropriate low-density lipoprotein cholesterol lowering therapy in secondary prevention of Japanese patients?
31 August 2019 (11:00 - 16:00)
Organised by:
Abstract
About the speaker
Shimane University Faculty of Medicine, Izumo (Japan)
14 More presentations in this session
Access the full session
The Event
ESC Congress 2019
31 August 2019
11:00 CET
